Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer

Lignende værker

• Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma
  af: Baba, Yuh, et al.
  Udgivet: (2017)
• Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
  af: Yuh Baba, et al.
  Udgivet: (2015-01-01)
• Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
  af: Baba, Yuh, et al.
  Udgivet: (2015)
• Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
  af: Kanke, Minoru, et al.
  Udgivet: (2000)
• Preclinical modeling of EGFR inhibitor resistance in head and neck cancer
  af: Quesnelle, Kelly M., et al.
  Udgivet: (2012)